Description

XMP-629 (XOMA-629), a cationic α-helical peptide, is a potent endotoxin inhibitor. XMP-629 exhibits broad-spectrum antimicrobial activity via an immunomodulatory mechanism. XOMA 629 has antimicrobial activity against Propionibacterium acnes, Staphylococcus aureus and Streptococcus pyogenesand[1][2].—COVID-19-immunoregulation–C67H93N15O11—-[1]Hancock RE, et, al. Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol. 2012 Mar 16;10(4):243-54.|[2]Bhopale GM. Antimicrobial Peptides: A Promising Avenue for Human Healthcare. Curr Pharm Biotechnol. 2020;21(2):90-96.–316805-65-9–1284.55—-NCCCC[C@@H](N)C(N[C@H](CC(C)C)C(N[C@H](CC1=CC=CC=C1)C(N[C@H](CCCNC(N)=N)C(N[C@@H](C(N[C@H](CCC(N)=O)C(N[C@H](C)C(N[C@H](CCCCN)C(N[C@@H](C(O)=O)CC2=CC=CC3=C2C=CC=C3)=O)=O)=O)=O)CC4=CC=CC5=C4C=CC=C5)=O)=O)=O)=O–Infection; Inflammation/Immunology–10 mM in DMSO–Antibiotic;Bacterial—-Anti-infection–Peptides